Serial Number | 97514013 |
Word Mark | FOPEBI |
Filing Date | Thursday, July 21, 2022 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Wednesday, August 14, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 26, 2023 |
Goods and Services | Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disorders |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 11, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Clementia Pharmaceuticals Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Montreal, Quebec H3B2V6 CA |
Party Name | Clementia Pharmaceuticals Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Montreal, Quebec H3B4W5 CA |
Event Date | Event Description |
Thursday, August 11, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, July 25, 2022 | NEW APPLICATION ENTERED |
Friday, February 10, 2023 | ASSIGNED TO EXAMINER |
Thursday, February 16, 2023 | PRIORITY ACTION WRITTEN |
Thursday, February 16, 2023 | PRIORITY ACTION E-MAILED |
Thursday, February 16, 2023 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Tuesday, May 16, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Tuesday, May 16, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Monday, August 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, August 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, August 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, August 22, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, September 26, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, September 6, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 26, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, November 21, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, December 19, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, December 19, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, December 19, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, February 29, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, August 14, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, August 14, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, August 14, 2024 | SOU EXTENSION 2 FILED |
Wednesday, August 14, 2024 | SOU EXTENSION 2 GRANTED |
Friday, March 1, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, February 29, 2024 | SOU EXTENSION 1 FILED |
Thursday, February 29, 2024 | SOU EXTENSION 1 GRANTED |